Fluor Corporation Faces Class Action Lawsuit: Investors Can Act Now for Recovery
Fluor Corporation (NYSE: FLR) is currently embroiled in a significant class action lawsuit that presents a crucial opportunity for investors who have suffered significant financial losses recently. Robbins Geller Rudman & Dowd LLP, a prominent law firm specializing in investor claims, has announced that those who purchased or acquired Fluor securities from
February 18, 2025 to
July 31, 2025 can step forward as potential lead plaintiffs in this lawsuit. The deadline for investors to take action is set for
November 14, 2025.
Details of the Lawsuit
The lawsuit, officially identified as
Maglione v. Fluor Corporation, No. 25-cv-02496 (N.D. Tex.), accuses Fluor and several of its key executives of violating the
Securities Exchange Act of 1934. The allegations highlight that the executives made misleading statements regarding the company's financial health and the various risks that could impact their infrastructure projects.
Fluor Corporation, known for its expertise in engineering, procurement, and construction, has been involved in high-profile projects like the
Gordie Howe International Bridge and the
Interstate 365 Lyndon B. Johnson highways in Texas. However, according to the complaint, the defendants concealed the fact that costs associated with these projects were ballooning due to 'subcontractor design errors, price increases, and scheduling delays.' Such information may have led investors to make decisions that ultimately resulted in significant financial losses.
The core allegations further state that a reduction in capital spending from their clients and the overall caution due to economic uncertainties were bound to adversely affect Fluor's business operations and financial outcomes. This overstated confidence in Fluor's performance misled investors regarding the reliability of their financial guidance for
fiscal year 2025.
Financial Implications
The impact of these issues came to a head on
August 1, 2025, when Fluor reported its second-quarter results, revealing a non-GAAP earnings per share of
$0.43, which was
$0.13 below expectations. Additionally, the reported revenue of
$3.98 billion signified a
5.9% year-over-year decline, missing estimates by
$570 million. The disappointing results were attributed to rising expenses tied to construction projects and reduced client capital spending, leading to a shave off over
27% of Fluor's stock price following these announcements.
The Role of Lead Plaintiffs
Given the complexities of class action lawsuits under the
Private Securities Litigation Reform Act of 1995, it is vital for affected investors to understand the role of a lead plaintiff. This individual is typically chosen based on their financial stake in the case and ability to represent the interests of the larger group. They also have the authority to select legal representation for the lawsuit.
Investors interested in serving as lead plaintiffs can either communicate through Robbins Geller or visit the law firm's dedicated page for the Fluor class action lawsuit for guidance. Importantly, participating in this legal action neither ensures a potential recovery nor mandates involvement as a lead plaintiff for those wishing to seek recovery in this matter.
About Robbins Geller
Robbins Geller Rudman & Dowd LLP is recognized globally for its representation of investors in securities fraud cases and shareholder litigations. According to recent reports, they ranked
#1 in securing monetary relief for investors, amounting to over
$2.5 billion in 2024 alone. Their history of securing substantial recoveries underscores the law firm's foothold in investor protection.
For these reasons, affected investors should consider their options carefully and understand their rights regarding the ongoing situation with Fluor Corporation.
For more details and to connect with attorneys involved in this case, interested parties can contact J.C. Sanchez or Jennifer N. Caringal of Robbins Geller directly.
Robbins Geller Rudman & Dowd LLP
655 W. Broadway, Suite 1900, San Diego, CA 92101
Phone: 800-449-4900